MACQUARIE GROUP LTD - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$632,000
-22.5%
20,0000.0%0.00%0.0%
Q2 2023$816,000
+9.5%
20,0000.0%0.00%0.0%
Q1 2023$745,000
+6.7%
20,0000.0%0.00%0.0%
Q4 2022$698,000
-41.3%
20,000
-2.3%
0.00%0.0%
Q3 2022$1,190,000
+8.1%
20,479
-3.7%
0.00%0.0%
Q2 2022$1,101,000
-28.7%
21,2720.0%0.00%0.0%
Q1 2022$1,545,000
-38.6%
21,2720.0%0.00%
-50.0%
Q4 2021$2,515,000
-13.0%
21,272
-1.3%
0.00%0.0%
Q3 2021$2,892,000
-14.2%
21,559
+3.5%
0.00%
-33.3%
Q2 2021$3,372,000
+96.7%
20,829
-2.5%
0.00%
+50.0%
Q1 2021$1,714,000
+44.8%
21,357
-1.9%
0.00%0.0%
Q4 2020$1,184,000
+173.4%
21,7730.0%0.00%
+100.0%
Q3 2020$433,000
-5.3%
21,7730.0%0.00%0.0%
Q2 2020$457,000
+11325.0%
21,773
+7157.7%
0.00%
Q4 2018$4,000
+33.3%
300
+200.0%
0.00%
Q3 2018$3,000
-97.0%
100
-97.3%
0.00%
Q2 2018$101,0003,7000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders